About Index Trending news
Analyze
Pricing
NeuroMetrix, Inc.

NeuroMetrix, Inc.

Work at NeuroMetrix, Inc.? Add yourself to this profile

NeuroMetrix, Inc.

NeuroMetrix is a medical device company focused on the diagnosis and treatmentof the neurological complications of diabetes.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding Show all
Post-IPO equity
$7,000,000
Post-IPO equity
$26,500,000
Employees

Team size

50+
Locations
HQ
Headquarters
$7,000,000 Post-IPO equity
businesswire

NeuroMetrix Closes $7.0 Million Private Placement of Preferred Stock and Warrants | Business Wire

$26,500,000 Post-IPO equity
MassDevice

NeuroMetrix raises $27m to buy back convertible shares, warrants

$21,000,000 Post-IPO equity
MassDevice

NeuroMetrix jumps on $21m round as Quell pain device hits 1k retail stores

$13,800,000 Post-IPO equity
BioPortfolio

NeuroMetrix Closes $13.8 Million At-The-Market Private Placement